Identification of genomic changes associated with cisplatin resistance in testicular germ cell tumor cell lines.
Since the introduction of cisplatin into the clinic, the treatment of patients with a variety of solid tumors including testicular germ cell tumors, ovarian and lung cancers, has dramatically improved. One of the main causes for therapeutic failure in these malignancies is the development of drug re...
Hoofdauteurs: | Noel, E, Perry, J, Chaplin, T, Mao, X, Cazier, J, Joel, S, Oliver, RT, Young, B, Lu, Y |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
2008
|
Gelijkaardige items
-
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors
door: André van Helvoort Lengert, et al.
Gepubliceerd in: (2022-08-01) -
Testicular germ cell tumors
door: Peter Albers
Gepubliceerd in: (2021-04-01) -
Immunotherapy in Testicular Germ Cell Tumors
door: Katarina Kalavska, et al.
Gepubliceerd in: (2020-09-01) -
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
door: Meineke Viktor, et al.
Gepubliceerd in: (2011-05-01) -
p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
door: Matthias Gutekunst, et al.
Gepubliceerd in: (2011-01-01)